Mortality trends for tuberculosis and sarcoidosis in English populations, 1979-2008

International Journal of Tuberculosis and Lung Disease

Volumn 16, Issue 1, 2012, Pages 38-42

  Duncan, M E ^a   Goldacre, Michael J ^a  

^a UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

Death certificate; England; Mortality; Sarcoidosis; Tuberculosis

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CAUSE OF DEATH; DEATH CERTIFICATE; FEMALE; HUMAN; LUNG SARCOIDOSIS; LUNG TUBERCULOSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; PREVALENCE; PRIORITY JOURNAL; UNITED KINGDOM;

ADOLESCENT; ADULT; AGED; CAUSE OF DEATH; DEATH CERTIFICATES; ENGLAND; FEMALE; HUMANS; MALE; MIDDLE AGED; MORTALITY; REGISTRIES; SARCOIDOSIS, PULMONARY; STATE MEDICINE; TIME FACTORS; TUBERCULOSIS, PULMONARY; YOUNG ADULT;

EID: 84555220663     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: 10.5588/ijtld.11.0077     Document Type: Article

References (20)

1. World Health Organization, Stop TB Partnership. 2009 update: tuberculosis facts. Geneva, Switzerland: WHO, 2009. http://www.who.int/tb/publications/2009/ tbfactsheet-2009update-one-page.pdf Accessed October 2011.
2. World Health Organization Regional Office for South-East Asia. TB in South-East Asia. New Delhi, India: WHO SEARO, 2009. http://www.searo.who.int/en/ Section10/Section2097/Section2100-10639.htm Accessed October 2011.
3. Hickson K J. The value of tuberculosis elimination and of progress in tuberculosis control in twentieth-century England and Wales. Int J Tuberc Lung Dis 2009; 13: 1061-1067.
4. Health Protection Agency Centre for Infections. Tuberculosis in the UK: annual report on tuberculosis surveillance in the UK, 2010. London, UK: HPA, 2010.
5. Newman L S, Rose C S, Maier L A. Sarcoidosis. N Engl J Med 1997; 336: 1224-1234. (Pubitemid 27183653)
6. Smith G, Brownell I, Sanchez M, Prystowsky S. Advances in the genetics of sarcoidosis. Clin Genet 2008; 73: 401-412. (Pubitemid 351517253)
7. Rajoriya N, Wotton C J, Yeates D G R, Travis S P L, Goldacre M J. Immune-mediated and chronic inflammatory disease in people with sarcoidosis: disease associations in a large UK database. Postgrad Med J 2009; 85: 233-237.
8. Porter N, Beynon H L, Randeva H S. Endocrine and reproductive manifestations of sarcoidosis. QJM 2003; 96: 53-61.
9. Sharma O P. Sarcoidosis around the world. Clin Chest Med 2008; 29: 357-363. (Pubitemid 351778214)
10. Nunes H, Bouvry D, Soler P, Valeyre D. Sarcoidosis. Orphanet J Rare Dis 2007; 2: 46.
11. Jones N, Mochizuki M. Sarcoidosis: epidemiology and clinical features. Ocul Immunol Inflamm 2010; 18: 72-79.
12. Gribbin J, Hubbard R B, Le J I, Smith C J, West J, Tata L J. Incidence and mortality of idiopathic pulmonary fibrosis and sarcoidosis in the UK. Thorax 2006; 61: 980-985. (Pubitemid 44787169)
13. Reich J M. Mortality of intrathoracic sarcoidosis in referral vs. population-based settings. Influence of stage, ethnicity and corticosteroid therapy. Chest 2002; 121: 32-39. (Pubitemid 34114225)
14. Office for National Statistics. Mortality statistics. Cause. Review of the Registrar General on deaths by cause, sex and age in England and Wales, 2001. Series DH2 no 28. London, UK: Her Majesty's Stationery Office, 2001: xxiv-xxv.
15. World Health Organization. Manual of the international statistical classification of diseases, injuries and causes of death. 1975 revision. Vol 1. Geneva, Switzerland: WHO, 1977: pp 699-706.
16. World Health Organization. International statistical classification of diseases and related health problems. 10th revision. Vol 2. Geneva, Switzerland: WHO, 1993: pp 30-88.
17. Goldacre M J, Duncan M E, Cook-Mozaffari P, Griffith M. Trends in mortality rates comparing underlying-cause and multiple-cause coding in an English population 1979-1998. J Public Health Med 2003; 25: 249-253. (Pubitemid 37237079)
18. Fears R, Kaufmann S, ter Meulen V, Zumla A. Drug-resistant tuberculosis in the European Union: opportunities and challenges for control. Tuberculosis (Edinb.) 2010; 90: 182-187.
19. Carvalho A C, Migliori G B, Cirillo D M. Tuberculosis in Europe: a problem of drug resistance or much more? Expert Rev Respir Med 2010; 4: 189-200.
20. Espinal M A, Laszlo A, Simonsen L, et al. Global trends in resistance to anti-tuberculosis drugs. N Eng J Med 2001; 344: 1294-1303. (Pubitemid 32377203)